GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dian Diagnostics Group Co Ltd (SZSE:300244) » Definitions » 3-Year EBITDA Growth Rate

Dian Diagnostics Group Co (SZSE:300244) 3-Year EBITDA Growth Rate : -1.60% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Dian Diagnostics Group Co 3-Year EBITDA Growth Rate?

Dian Diagnostics Group Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.25.

During the past 12 months, Dian Diagnostics Group Co's average EBITDA Per Share Growth Rate was -63.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -1.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 16.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 32.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Dian Diagnostics Group Co was 62.00% per year. The lowest was -1.60% per year. And the median was 36.70% per year.


Competitive Comparison of Dian Diagnostics Group Co's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Dian Diagnostics Group Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dian Diagnostics Group Co's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dian Diagnostics Group Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Dian Diagnostics Group Co's 3-Year EBITDA Growth Rate falls into.



Dian Diagnostics Group Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Dian Diagnostics Group Co  (SZSE:300244) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Dian Diagnostics Group Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Dian Diagnostics Group Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Dian Diagnostics Group Co (SZSE:300244) Business Description

Traded in Other Exchanges
N/A
Address
No. 329, Jinpeng Street, 5th Floor, Building 2, Xihu District, Zhejiang, Hangzhou, CHN, 310030
Dian Diagnostics Group Co Ltd is an independent third-party medical diagnostic service provider that provides diagnostic services outsourcing as its core business. It promotes the development of multi-service areas of medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains, covering medical diagnostic services and diagnostic products.
Executives
Chen Hai Bin Director
Chen Shi Shi Supervisors
Guo San Hui Executives
Yao Shu Lie Executives
Xu Min Director
Wang Yan Xiao Directors, executives
Chen Zuo Xiu Directors, executives
Hu Yong Director
Hu Miao Shen Executives
Chen Xue Dong Director
Jiang Tang Directors, executives
Tao Jun Securities Affairs Representative
Wu Zheng Xin Executives
Cheng Xiu Li Supervisors

Dian Diagnostics Group Co (SZSE:300244) Headlines

No Headlines